Skip to main content

Table 1 Characteristics of patients in the intent-to-treat population

From: Impact of obesity, structural severity and their combination on the efficacy of viscosupplementation in patients with knee osteoarthritis

 

ITT population

(N = 205)

HANOX-M

(N = 103)

BioHA

(N = 102)

p-value

Age (years)

Mean (SD)

65.3 (10.5)

65.2 (10.1)

65.3 (10.9)

0.95

OARSI JSN

Grade 1–2 N (%)

119 (58%)

57 (55.4%)

62 (60.8%)

0.68

Grade 3 N (%)

86 (42%)

46 (44.7%)

40 (39.2%)

 

BMI (kg/m2)

Mean (SD)

27.59 (4.92)

27.72 (5.00)

27.47 (4.86)

0.72

WOMAC A baseline

Mean (SD)

9.7 (3.4)

9.7 (3.2)

9.7 (3.6)

0.98

WOMAC A endpoint

Mean (SD)

5.4 (4.2)

5.4 (4.0)

5.3 (4.4)

0.95

  1. WOMAC Western Ontario & McMaster Universities Osteoarthritis Index: pain (range 0–20), OARSI OsteoArthritis Research Society International score for joint space narrowing (JSN range 0–3), BMI Body Mass Index (kg/m2)